webinar: going beyond egfr: evaluating technologies for molecular genetic testing in nsclc
Published 4 years ago • 185 plays • Length 43:43Download video MP4
Download video MP3
Similar videos
-
4:27
molecular testing beyond egfr and alk in stage iv nsclc
-
56:48
webinar: detection of therapeutically targetable mutations in nsclc
-
1:59
limitations in genetic testing for lung cancer
-
58:16
webinar: analytical utility of mass-spec liquid biopsy for nsclc and melanoma samples
-
34:24
lung cancer gene fusion assays using nanostring® ncounter® technology
-
43:20
2022 liquid biopsy eqa for lung cancer (egfr) webinar - 28th june 2023
-
1:25:38
2021 liquid biopsy eqa for lung cancer (egfr) webinar - 21st april 2022
-
58:19
the implications of recent datasets for the current and future management of nsclc egfr mutations
-
5:04
how it works - genetic testing in lung cancer davies
-
1:04
molecular testing in egfr mutant driven nsclc
-
1:03:17
egfr positive webinar
-
41:48
live well, breathe better: lung cancer: genetic testing in lung cancer
-
56:16
biomarker testing for lung cancer webinar
-
16:27
debate: molecular profiling beyond egfr/alk - must be the standard
-
6:28
sequential treatment with afatinib and osimertinib in patients with egfr mutation-positive nsclc
-
37:01
biomarker testing for nsclc/sclc - early and late stage - 03/10/23 - lung cancer living room
-
1:01:27
molecular testing for egfr mutations: what pathologists need to know
-
58:51
disrupting the lung cancer care continuum with novel genomic tests